BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26508669)

  • 1. Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).
    Sargos P; Guerif S; Latorzeff I; Hennequin C; Pommier P; Lagrange JL; Créhange G; Chapet O; de Crevoisier R; Azria D; Supiot S; Habibian M; Soulié M; Richaud P
    Cancer Treat Rev; 2015 Dec; 41(10):814-20. PubMed ID: 26508669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
    Lawton CA; Michalski J; El-Naqa I; Buyyounouski MK; Lee WR; Menard C; O'Meara E; Rosenthal SA; Ritter M; Seider M
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):383-7. PubMed ID: 18947938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy.
    Shih HA; Harisinghani M; Zietman AL; Wolfgang JA; Saksena M; Weissleder R
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1262-9. PubMed ID: 16253781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients.
    Meijer HJ; Fortuin AS; van Lin EN; Debats OA; Alfred Witjes J; Kaanders JH; Barentsz JO
    Radiother Oncol; 2013 Jan; 106(1):59-63. PubMed ID: 23199653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.
    Harris VA; Staffurth J; Naismith O; Esmail A; Gulliford S; Khoo V; Lewis R; Littler J; McNair H; Sadoyze A; Scrase C; Sohaib A; Syndikus I; Zarkar A; Hall E; Dearnaley D;
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):874-83. PubMed ID: 26104940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy.
    Meijer HJ; van Lin EN; Debats OA; Witjes JA; Span PN; Kaanders JH; Barentsz JO
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1405-10. PubMed ID: 21640507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage.
    Spratt DE; Vargas HA; Zumsteg ZS; Golia Pernicka JS; Osborne JR; Pei X; Zelefsky MJ
    Eur Urol; 2017 Jan; 71(1):37-43. PubMed ID: 27523595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition.
    Ganswindt U; Paulsen F; Corvin S; Eichhorn K; Glocker S; Hundt I; Birkner M; Alber M; Anastasiadis A; Stenzl A; Bares R; Budach W; Bamberg M; Belka C
    BMC Cancer; 2005 Jul; 5():91. PubMed ID: 16048656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult pelvic lymph node involvement in bladder cancer: implications for definitive radiation.
    Goldsmith B; Baumann BC; He J; Tucker K; Bekelman J; Deville C; Vapiwala N; Vaughn D; Keefe SM; Guzzo T; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):603-10. PubMed ID: 24411628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
    Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literature review with PGI guidelines for delineation of clinical target volume for intact carcinoma cervix.
    Bansal A; Patel FD; Rai B; Gulia A; Dhanireddy B; Sharma SC
    J Cancer Res Ther; 2013; 9(4):574-82. PubMed ID: 24518699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphatic drainage and CTV in carcinoma of the prostate.
    Cellini N; Luzi S; Mantini G; Mattiucci GC; Morganti AG; Digesù C; Bavasso A; Deodato F; Smaniotto D; Valentini V
    Rays; 2003; 28(3):337-41. PubMed ID: 15018322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
    Lawton CA; Michalski J; El-Naqa I; Kuban D; Lee WR; Rosenthal SA; Zietman A; Sandler H; Shipley W; Ritter M; Valicenti R; Catton C; Roach M; Pisansky TM; Seider M
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):377-82. PubMed ID: 18947941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer.
    Meijer HJ; Debats OA; Kunze-Busch M; van Kollenburg P; Leer JW; Witjes JA; Kaanders JH; Barentsz JO; van Lin EN
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):175-83. PubMed ID: 21075555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
    Dapper H; Schiller K; Münch S; Peeken JC; Borm K; Weber W; Combs SE
    BMC Cancer; 2019 Jul; 19(1):742. PubMed ID: 31357959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT.
    Vees H; Steiner C; Dipasquale G; Chouiter A; Zilli T; Velazquez M; Namy S; Ratib O; Buchegger F; Miralbell R
    Radiat Oncol; 2012 Aug; 7():134. PubMed ID: 22873771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
    De Hertogh O; Le Bihan G; Zilli T; Palumbo S; Jolicoeur M; Crehange G; Derashodian T; Roubaud G; Salembier C; Supiot S; Chapet O; Achard V; Sargos P
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):29-40. PubMed ID: 37506982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins.
    Kershaw L; van Zadelhoff L; Heemsbergen W; Pos F; van Herk M
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):68-77. PubMed ID: 29051038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.